Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prediction of response to imatinib by cDNA microarray analysis.

Ryuzo Ohno1, Yusuke Nakamura

  • 1Aichi Cancer Center Hospital, Nagoya, Japan; and the Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.

Seminars in Hematology
|June 5, 2003
PubMed
Summary

Gene expression profiles can predict imatinib effectiveness in chronic myeloid leukemia (CML) patients. This approach may lead to personalized therapy, guiding treatment decisions for CML management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of landscape design on depth perception in classical Chinese gardens: A quantitative analysis using virtual reality simulation.

Frontiers in psychology·2022
Same author

A phase II randomized study evaluating azacitidine versus conventional care regimens in newly diagnosed elderly Japanese patients with unfavorable acute myeloid leukemia.

International journal of hematology·2022
Same author

Effect of Wall Texture on Perceptual Spaciousness of Indoor Space.

International journal of environmental research and public health·2020
Same author

Underweight status at diagnosis is associated with poorer outcomes in adult patients with acute myeloid leukemia: a retrospective study of JALSG AML 201.

Annals of hematology·2017
Same author

The demarcation between younger and older acute myeloid leukemia patients: a pooled analysis of 3 prospective studies.

Cancer·2013
Same author

[Anti-smoking education for tobacco-free society].

Nihon rinsho. Japanese journal of clinical medicine·2013

Area of Science:

  • Oncology
  • Genomics
  • Pharmacogenomics

Background:

  • Imatinib mesylate (Gleevec) significantly advances chronic myeloid leukemia (CML) treatment, achieving high response rates.
  • Predicting individual patient response to imatinib is crucial for optimizing CML management and considering stem cell transplantation (SCT).

Purpose of the Study:

  • To analyze gene expression profiles of CML patients treated with imatinib.
  • To identify gene expression patterns that differentiate responders from nonresponders.
  • To develop a predictive model for imatinib effectiveness in CML.

Main Methods:

  • Analysis of peripheral leukemia cell gene expression profiles from 18 CML patients using cDNA microarrays (23,040 genes).
  • Identification of differentially expressed genes between responders and nonresponders.

Related Experiment Videos

  • Development of a prediction score system using selected genes.

    • Main Results:

    • 79 differentially expressed genes were identified between responders and nonresponders.
    • A prediction score system using 15 or 30 genes successfully distinguished responders from nonresponders.
    • The prediction model was validated in four additional patients, accurately predicting their responses.

    Conclusions:

    • Gene expression profiling can predict the clinical effectiveness of imatinib in CML patients.
    • This predictive capability supports the development of personalized therapy strategies for CML.
    • Gene expression analysis offers a promising tool for tailoring imatinib treatment in CML.